As DMEK surgery slowly becomes more popular as a treatment for endothelial dysfunction, it is important to assess if it is possible to safely reduce the use of corticosteroids after surgery.
Powered by Suchmaschinenoptimierung
AAO News Archive
- Deal struck to develop integrin antagonist treatment
- New low-add multifocal IOLs yield higher patient satisfaction
- Regeneron, Bayer to develop AMD combination therapy
- FDA approves wide-field imaging system for newborns
- Brain mapping may someday lead to vision-restoring therapies
- FDA warns of loose safety seals on eye drops
- Stem cells regrow human lens, corneal tissue
Loteprednol prevents graft rejection with less IOP risk
- Details